Profile for Fate Therapeutics Inc. (FATE)

$ 33.21   -2.05 (-5.81%) Volume: 793.29k 4:00 PM EDT Jul 13, 2020
After Hours:  $ 33.75   0.54 (+1.63%) Volume: 30.73k 7:10 PM EDT Jul 13, 2020
Business Description:
Fate Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the development of programmed cellular immunotherapies for cancer and immune disorders.
Address: 3535 General Atomics Court, Suite 200, San Diego, CA, USA, 92121
Telephone: +1 858 875-1800 Website:
Facsimile: N/A Email: [email protected]
CEO: J. Scott Wolchko
Employees: 178 Market Cap: 2.87b
Issue Type: CS
Auditor: Ernst & Young LLP
Last Audit: Unqualified Opinion with Explanation
Indices: N/A
Industry Classifications
Sector: Healthcare CIK: 1434316
Industry: Biotechnology
Sub-Industry:    Biotechnology
NAICS: Pharmaceutical Preparation Manufacturing (325412)
SIC: Biological Products, Except Diagnostic Substances (2836)